Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

gemcitabine-oxaliplatin regimen

Known as: GEM-OX Regimen, GEMOX Regimen 
A regimen consisting of gemcitabine and oxaliplatin used for the treatment of biliary adenocarcinoma, pancreatic cancer, hepatocellular cancer and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive neoplasm with a poor outcome. Novel L-asparaginase-based… Expand
  • figure 1
  • figure 2
  • table 4
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND Previous clinical trials have not proved that adding epidermal growth factor receptor inhibitors to chemotherapy… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE Our aim was to investigate the hypothesis that the CT perfusion (CTP) is a more sensitive image biomarker when compared… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2010
2010
Backgrounds: The combination gemcitabine-oxaliplatin (GEMOX) is frequently used in patients with advanced biliary tract carcinoma… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
PurposeChemotherapy represents a palliative treatment, with poor response rates and a median survival of less than 6 months in… Expand
  • figure 2
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
4520 Background: There is no standard regimen for palliative chemotherapy of advanced biliary cancers. The GEMOX regimen is an… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND New systemic therapies are needed to improve the prognosis of patients with advanced-stage hepatocellular carcinoma… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Gemcitabine and oxaliplatin (GEMOX) are active as first-line therapy against advanced pancreatic cancer. This study aims to… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2006
2006
PURPOSE To evaluate the activity and tolerance of gemcitabine in combination with oxaliplatin (GEMOX regimen) in pretreated… Expand
Is this relevant?
2004
2004
Background : High-dose therapy with autologous stem cell support (HDT) is an established treatment for chemosensitive relapse in… Expand
Is this relevant?